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 Decreased junctophilin-2 levels are
associated with cardiac t-tubule
derangements in mdx mice, the mouse
model of Duchenne muscular dystrophy
(DMD).
 Reduced junctophilin-2 protein levels
correlate with increases in total microtu-
bule content in mdx hearts.
 Colchicine-mediated microtubule depoly-
merization increases junctophilin-2 pro-
tein levels and improves localization
patterns which, in turn, are associated
with t-tubule reorganization and reduced
calcium sparks.
 This study identiﬁes microtubule-
mediated misregulation of junctophilin-2
as a novel molecular mechanism in
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123SUMMARYCardiac myocytes from the mdx mouse, the mouse model of Duchenne muscular dystrophy, exhibit t-tubule
disarray and increased calcium sparks, but a unifying molecular mechanism has not been elucidated. Recently,
improper trafﬁcking of junctophilin (JPH)-2 on an alteredmicrotubule network caused t-tubulederangements and
calcium mishandling in a pressure-overload heart failure model. Mdx cardiac myocytes have microtubule abnor-
malities, but how this may affect JPH-2, t-tubules, and calcium handling has not been established. Here, we
investigated the hypothesis that an inverse relationship between microtubules and JPH-2 underlies t-tubule
disruptions and calcium mishandling in mdx cardiac myocytes. Confocal microscopy revealed t-tubule disorga-
nization inmdx cardiac myocytes. QuantitativeWestern blot analysis demonstrated JPH-2 was decreased by 75%
and showed an inverse hyperbolic relationship with a- and b-tubulin, the individual components of microtubules,
inmdxhearts. Colchicine-inducedmicrotubuledepolymerization normalized JPH-2 protein levels and localization,
corrected t-tubule architecture, and reduced calcium sparks. In summary, these results suggest microtubule-
mediated misregulation of JPH-2 causes t-tubule derangements and altered calcium handling in mdx cardiac
myocytes. (J Am Coll Cardiol Basic Trans Science 2016;1:122–30) © 2016 The Authors. Published by Elsevier on
behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).AB BR EV I A T I O N S
AND ACRONYM S





SR = Sarcoplasmic reticulum
TT = transverse tubules
VGCC = voltage-gated calcium
channel
WT = wild-typeL oss of dystrophin causes Duchenne musculardystrophy (DMD), an X-linked disease charac-terized by striated muscle dysfunction result-
ing in a life expectancy of only 20 years to 30 years
(1). Heart failure is the cause of death for 20% to 25%
of DMDpatients (2); therefore research aimed at under-
standing the molecular and cellular phenotypes
underlying the cardiomyopathy of DMD has been
conducted. Altered calcium homeostasis marked by
increased calcium sparks (3–5) and t-tubule disarray
were documented in cardiac myocytes from the
dystrophin-deﬁcient mdx mouse (6,7), but a unifying
molecular mechanism has not been identiﬁed.
Junctophilin (JPH)-2, the protein that links the
plasma membrane of t-tubules to the ryanodine re-
ceptor, is essential for proper t-tubule structure and
function (8). Recently, it was reported that JPH-2
mislocalization due to abnormalities in microtubule
cytoskeleton caused pathological t-tubule remodeling
and abnormal calcium handling in the pressure
overload-induced heart failure model (9). However,
the relationship between microtubules and JPH-2 in
other models of heart failure or cardiomyopathy has
not been analyzed. Because previous studies docu-
mented microtubule derangements in mdx cardiac
myocytes (5,10), we tested the hypothesis that
microtubule alterations cause JPH-2 misregulation
and result in t-tubule disruptions and calcium mis-
handling in mdx mice.
Finally, to investigate the translational aspects of
our hypothesis, we examined the cardiomyopathy of
mdx mice via echocardiography and isoproterenol
stress tests as previous studies showedmildly reduced
systolic function (11–14) and excessive mortality withisoproterenol administration (10,15,16) in mdx mice.
Because Zhang et al. (9) and Guo et al. (17) showed
improvement in systolic function with normalization
of JPH-2, we hypothesized colchicine-induced JPH-2
normalization would reduce the severity of mdx
cardiomyopathy.
METHODS
MICE. Control C57BL/10 and mdx mice were pur-
chased from Jackson Laboratories. All animals were
housed and treated following the guidelines set forth
by the University of Minnesota Institutional Animal
Care and Use Committee.
ANTIBODIES. Polyclonal antibodies for voltage-gated
calcium channel (VGCC) (Sigma, Waltham, Massa-
chusetts) and JPH-2 (ThermoScientiﬁc) and mono-
clonal antibodies for a-tubulin (Sigma), b-tubulin
(Sigma), and dystrophin (Leica, Buffalo Grove, Illi-
nois) were purchased from the identiﬁed vendors.
Alexa-Fluor-488 or Alexa-Fluor-568conjugated
anti-rabbit antibodies were purchased from
Molecular Probes (Eugene, Oregon). Infrared
dye-conjugated anti-mouse and anti-rabbit
antibodies were purchased from LICOR Bio-
sciences (Lincoln, Nebraska).
ISOLATION OF CARDIAC MYOCYTES. Isola-
tion of ventricular cardiac myocytes was
performed as described previously (18).
T-TUBULE ASSESSMENT. Freshly isolated
cardiac myocytes were ﬁxed in 4% para-
formaldehyde for 10 min at 37C, washed with
phosphate-buffered saline (PBS) 2 times for 5
min, incubated with AlexaFluor 488
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124conjugated Wheat Germ Agglutinin (Sigma) for 10 min
at room temperature, and then washed in PBS 2 times
for 5 min. Cells were mounted in Antifade (Molecular
Probes) and imaged on Bio-Rad MRC 1000 scan head
mounted on an upright Nikon Optishot microscope
(Tokyo, Japan) at the University Imaging Centers at the
University of Minnesota. Z-stacks were collected and
converted into a z-projection using ImageJ (Bethesda,
Maryland). T-tubule quantiﬁcation was performed
using the TTPower plugin on ImageJ as described (7).
IMMUNOFLUORESCENCE ANALYSIS. Primary cardiac
myocytes were ﬁxed in 4% paraformaldehyde for 10
min at 37C, permeabilized with 1% Triton X-100
(Sigma) in PBS, blocked in 5% BSA for 10 min 3 times,
and incubated with primary antibodies overnight at
4C. Sections were then washed and blocked with 5%
bovine serum albumin for 10 min 3 times and then in-
cubated with Alexa-Fluor-488- or Alexa-Fluor-568
conjugated secondary antibodies for 30 min at 37C.
Then, cardiac myocytes were washed with PBS and
mounted in Anti-Fade Reagent (Molecular Probes).
CALCIUM TRANSIENT MEASUREMENTS. Freshly iso-
lated cardiac myocytes were loaded with Fura-2AM
(a ratiometric Ca2þ indicator; 2 mM [Molecular
Probes]) for 10 min at room temperature after a
de-esteriﬁcation period of 20 min in M199 medium
(Sigma). Cells were incubated with 10 mm colchicine or
vehicle (double-distilled water [ddH2O]) for 2 h and
then subjected to calciumanalysis. Fura-2ﬂuorescence
was measured using a spectrophotometer (Stepper
Switch, IonOptix). Initially, Fura-2 was excited at 360
nm (the isosbestic point independent of Ca2þ) and then
continuously at 380 nm (Ca2þ-dependent ﬂuores-
cence). Emission was collected at >510 nm by a pho-
tomultiplier tube. Ratiometric data were collected and
analyzedonlineusing commercial software (IonOptix).
CALCIUM SPARK ANALYSIS. Freshly isolated adult
cardiac myocytes were plated on glass coverslips
coated with 10 mg/ml laminin and in M199 medium
and allowed to attach for 2 h. Then, colchicine (10
mM) or vehicle was added for 2 h. Cardiac myocytes
were loaded with Ca2þ indicator Fluo 8-AM (5 mM,
AAT Bioquest, Sunnyvale, California) for 10 min at
room temperature followed by washout. For confocal
imaging, we used an inverted confocal microscope
(Leica TCS SP8, Wetzlar, Germany) with a 40, 1.3
NA oil-immersion objective. Fluo 8-AM was excited
at 488 nm and the emission was collected at >505
nm. For Ca2þspark imaging, line scan was performed
at a speed of 1.43 ms/line for 1,000 lines.
SARCOPLASMIC RETICULUM LOAD ANALYSIS.
Freshly isolated cardiac myocytes plated on
laminin-coated coverslips were treated with 10 mMcolchicine or vehicle for 2 h and were then loaded
with 2 mM Fura-2AM for 10 min and de-esteriﬁed for
10 min at room temperature. After de-esteriﬁcation,
coverslips were mounted onto a perfusion chamber
and perfused with modiﬁed Tyrode’s solution (in
mM: 140 NaCl, 0.5 MgCl2, 5 HEPES, 5.5 glucose, 1.8
CaCl2, 5 KCl; pH 7.4) at 30C. Myocytes were paced at
0.5 Hz for at least 20 s after which pacing was stopped
and the perfusate was switched to Tyrode’s solution
with 20 mM caffeine to measure the sarcoplasmic
reticulum calcium load. Finally, myocytes were again
perfused with Tyrode’s solution and paced at 0.5 Hz
to ensure they were still viable. No more than 2
myocytes were measured per coverslip. Transient
data were collected by measuring the 360:380 ratio
using the Ionoptix Calcium and Contractility System
and data were analyzed using IonWizard software
(Westwood, Massachusetts).
IMAGE PROCESSING. Confocal images were collected
and equivalently processed using Adobe Photoshop
Version CS6 (San Jose, California).
WESTERN BLOT ANALYSIS AND QUANTIFICATION.
Whole protein extracts from isolated ventricles from
mice were performed as described (19). Protein con-
centration was determined using a BCA protein assay
kit (Pierce, Waltham, Massachusetts). Cardiac ex-
tracts (25 mg) were subjected to sodium dodecyl sul-
fatepolyacrylamide gel electrophoresis (SDS-PAGE)
and then transferred to nitrocellulose membrane.
Membranes were washed/blocked in 5% milk in PBS
for 1 h, and incubated with primary antibodies for 1 h
at room temperature. Membranes were then wash-
ed/blocked twice for 10 min in 5% milk in PBS and
then incubated with infrared secondary antibodies
for 30 min at room temperature. Membranes were
washed in Tris-buffered saline containing 0.1% Tween
(Sigma) twice for 5 min. Imaging and quantiﬁcation of
Western blots was performed on an Odyssey Infrared
Imaging system. SDS-PAGE was performed in parallel
and stained with Coomassie brilliant blue stain and
was imaging at the 700 nmwavelength on the Odyssey
Imaging system (Lincoln, Nebraska) to serve as the
loading control as described (20).
CHRONIC COLCHICINE TREATMENT. Mice were
treated with intraperitoneal injection of either
ﬁlter-sterilized PBS or 0.5 mg/kg of ﬁlter-sterilized
colchicine (Sigma) dissolved in PBS every other day
for 2 weeks.
ECHOCARDIOGRAPHY. Echocardiographic analysis
was conducted using a VisualSonics 2100 ultrasound
machine (Toronto, Ontario, Canada) with mice anes-
thetized with 2% to 3% inhaled isoﬂurane. Heart rate
had to be >400 beats/min during echocardiographic
FIGURE 1 T-Tubule Derangements in mdx Mice Are Associated With JPH-2 Misregulation
(A) Representative confocal images of cardiac myocytes stained with wheat germ agglutinin to delineate t-tubules. Older (8 months to 10
months) but not young (2 months to 3 months) mdx mice showed loss of regularity of the t-tubule network. Scale bar equals 5 mm. (B)
Quantiﬁcation of t-tubule organization in older (8 months to 10 months of age) WT, young, and older mdx mice. There was a signiﬁcant
reduction in t-tubule regularity in aged mdx mice. An asterisk (*) indicates p # 0.05 when compared to WT; A pound symbol (#) indicates
p # 0.05 when compared to young mdx as determined by 1-way ANOVA with Tukey post-hoc analysis. N ¼ 17 cells to 20 cells per genotype
from 2 animals to 3 animals per genotype. Representative Western blot analyses and subsequent quantiﬁcation from cardiac extracts of young
(ages 2 months to 3 months) (C and D) and older (8 months to 10 months) (E and F)WT andmdxmice along with CBB stained SDS-PAGE, which
served as a loading control. There was no difference in VGCC but there was a signiﬁcant 75% reduction in JPH-2 levels in older mdx mice
(p ¼ 0.0003). N ¼ 3 animals to 4 animals per genotype per age. (G) Representative confocal micrographs of cardiac myocytes from aged-
matched (8 months to 10 months) control and mdx cardiac myocytes stained for JPH-2. Scale bar equals 5 mm. (H) Quantiﬁcation of JPH-2
localization using TTPower. Older mdx mice showed altered localization of JPH-2 in cardiac myocytes (p < 0.0001). N ¼17 cells to 19 cells from
2 animals to 3 animals per treatment. An asterisk (*) indicates p # 0.05 as determined using Student t test. Values are presented as
mean  SEM. ANOVA ¼ analysis of variance; CBB ¼ Coomassie brilliant blue; JPH-2 ¼ junctophilin-2; SDS-PAGE ¼ sodium dodecyl
sulfatepolyacrylamide gel electrophoresis; VGCC ¼ voltage-gated calcium channel; WT ¼ wild-type.
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125analysis. Systolic and diastolic dimensions and frac-
tional shortening were determined from M-mode
images in the parasternal short-axis view at the level
of the mitral valve.
ISOPROTERENOL STRESS TESTS. Eight-month to
10-month-old wild-type (WT) and mdx mice (n ¼ 8
mice to 10 mice per treatment group) were treated
with either PBS or colchicine for 2 weeks and then
administered isoproterenol at a dose 10 mg/kg at9AM, 1PM, and 5PM via intraperitoneal injection for
3 consecutive days. Survival was assessed at 8-h
intervals for the ﬁrst 5 days and then daily
thereafter.
STATISTICAL ANALYSIS. All data are represented as
mean  standard error of the mean. Student t tests
were used to compare 2 groups with assumed equiv-
alent variance if sample size was <5 with an F-test to
assess variance if sample size was >5 and 1-way
FIGURE 2 Negative Hyperbolic Relationship Between JPH-2 and Tubulin in
Aged mdx Cardiac Extracts
Quantitative Western blot analysis of a- and b-tubulin levels in young (A and B) and aged
(C and D) mdx mice. There was no signiﬁcant difference in tubulin levels in young
(2 months to 3 months of age) mice but older (8 months to 10 months of age) mdx mice
showed a signiﬁcant 2.6-fold increase in a- and b-tubulin protein expression. (For
a-tubulin comparison, p ¼ 0.0008. For b-tubulin comparison, p ¼ 0.0007.) N ¼ 3 animals
to 4 animals per genotype per age point. (E and F) A strong negative hyperbolic relation
between JPH-2 and a- and b-tubulin in older mdx cardiac extracts exists (r2 ¼ 0.95 for
a-tub and JPH-2 curve-ﬁtting, and r2 ¼ 0.95 for b-tubulin and JPH-2 curve ﬁtting).
*p # 0.05 as determined using Student t test. Values are presented as mean  SEM.
Abbreviations as in Figure 1.
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126analysis of variance with Tukey post-hoc test
was used to compare means between 3 groups.
Kaplan-Meier survival curve was used to determine
survival differences after initial treatment with
isoproterenol with log-rank test to assess differences
in survival. Statistical signiﬁcance was deﬁned as
p # 0.05.RESULTS
T-TUBULE DISRUPTIONS IN mdx CARDIAC MYOCYTES
ARE ASSOCIATED WITH REDUCED JPH-2 PROTEIN
LEVELS AND ALTERED LOCALIZATION. We ﬁrst
analyzed the t-tubule network in isolated cardiac
myocytes from young (2- to 3-months old) and older
(8- to 10-months old) WT and mdx mice. The 8- to
10-month time was used because that is the age when
mdx mice begin to show signs of cardiomyopathy
(12,14). When compared to 8-month to 10-months of
age, WT and young mdx cardiac myocytes had no
discernable difference in t-tubule architecture, but
older mdx cardiac myocytes showed disrupted
t-tubules (Figure 1A). When quantiﬁed using TTPower
analysis, older mdx t-tubule structural integrity (39.2
 2.2 AU) was signiﬁcantly different than WT (57.3 
1.3 AU) and young mdx mice (56.8  2.3 AU)
(Figure 1B).
To provide insight into the mechanism of t-tubule
disruptions in older mdx mice, we investigated 2 key
t-tubule proteins: the VGCC and JPH-2. Protein levels
of VGCC were not altered in either young or older
mdx heart extracts (Figures 1C to 1F). However, JPH-2
protein levels were markedly reduced by 75% in older
mdx hearts (WT: 1  0.9 AU and mdx: 0.024  0.4 AU)
but not signiﬁcantly altered in young mice (WT: 1.0 
0.1 AU and mdx: 1.3  0.2 AU) (Figures 1C to 1F),
a pattern that mirrored the t-tubule phenotype.
Immunoﬂuorescence analysis of isolated cardiac
myocytes from older WT (74.2  1.9 AU) and mdx
mice (57.8  1.7 AU) revealed altered localization of
JPH-2 in mdx mice (Figures 1G and 1H). In summary,
JPH-2 misregulation was associated with t-tubule
disruptions in mdx hearts.
INVERSE HYPERBOLIC RELATIONSHIP BETWEEN
JPH-2 AND a- AND b-TUBULIN. Because a previous
report demonstrated that an altered microtubule
cytoskeleton caused mislocalization of JPH-2 (9), we
analyzed the relationship between a- and b-tubulin,
the individual components of microtubules, and
JPH-2 in mdx hearts. At a young age when JPH-2
levels were normal, a-tubulin (WT: 1.0  0.1 AU and
mdx: 1.2  0.1 AU) and b-tubulin (WT: 1.0  0.2 AU and
mdx: 1.3  0.1 AU) protein expression was not
signiﬁcantly different in mdx cardiac extracts
(Figures 2A and 2B). However, in older mdx hearts
when JPH-2 protein was reduced, a-tubulin (WT: 1.0
 0.1 AU and mdx: 2.7  0.3 AU) and b-tubulin
(WT: 1.0  0.9 AU and mdx: 2.5  0.2 AU) content was
increased approximately 2.6-fold (Figures 2C and 2D).
When the relationships between a- and b-tubulin and
JPH-2 in older mice was analyzed, we observed a
signiﬁcant inverse hyperbolic relationships (r2 ¼ 0.95
FIGURE 3 Microtubule Depolymerization Normalized JPH-2 Levels and Localization
and t-Tubule Morphology in mdx Mice
(A) Confocal micrographs of cardiac myocytes stained with an a-tubulin antibody to show
the microtubule cytoskeleton. Colchicine depolymerized microtubule in vivo. (B) Repre-
sentative Western blots and CBB-stained SDS-PAGE of extracts from mdx mice treated
with either PBS or colchicine. (C) JPH-2 was upregulated 7.6-fold in mice treated with
colchicine (p ¼ 0.0007). (D) Representative confocal micrographs showing JPH-2 levels
and localization. (E) Quantiﬁcation of JPH-2 localization using TTPower. JPH-2 localization
improved with colchicine treatment (p ¼ 0.04). N ¼ 20 cells to 22 cells from 2 animals to 3
animals per treatment. (F) Representative images of t-tubules stained with wheat germ
agglutinin from cardiac myocytes isolated from mdx treated with either PBS or colchicine.
(G) Quantiﬁcation of t-tubule organization using TTPower. Colchicine resulted in a signiﬁ-
cant improvement in t-tubule organization (p ¼ 0.02). N ¼ 19 cells to 20 cells per
treatment from 2 animals to 3 animals. An asterisk (*) indicates p # 0.05 as determined
using Student t test. Scale bar is 5 mm in all images. Values are presented as mean  SEM.
PBS ¼ phosphate-buffered saline; other abbreviations as in Figure 1.
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127for both curve ﬁtting models) (Figures 2E and 2F).
These data suggested increased microtubule content
was associated with reduced JPH-2 protein levels.
COLCHICINE-INDUCED MICROTUBULE DEPOLYMERIZATION
NORMALIZED JPH-2 LEVELS AND LOCALIZATION WHICH
CORRECTED T-TUBULE MORPHOLOGY IN mdx MICE. To
further probe the relationship between microtubules
and JPH-2 in mdx hearts, we treated older mdx mice
for 2 weeks with colchicine to induce microtubule
depolymerization and examined the effects on JPH-2
and t-tubules. Colchicine treatment effectively
depolymerized microtubules in cardiac myocytes
in vivo (Figure 3A) and was associated with a 7.6-fold
increase in JPH-2 protein levels (mdx-PBS: 1.0  0.08
AU and mdx-colchicine: 7.6  1.0 AU) (Figures 3B and
3C). Moreover, JPH-2 localization patterns in mdx
cardiac myocytes were signiﬁcantly improved with
colchicine treatment (mdx-PBS: 62.6  1.6 AU and
mdx-colchicine: 68.1  1.9 AU) (Figure 3D and 3E).
Finally, colchicine-mediated restoration of JPH-2
improved t-tubule organization in older mdx hearts
(mdx-PBS: 44.5  2.0 AU and mdx-colchicine: 52.5  2.
2 AU) (Figures 3F and 3G).
ACUTE COLCHICINE TREATMENT IMPROVED CALCIUM
HANDLING INmdx CARDIAC MYOCYTES. Because JPH-2
was shown to be an important regulator of the rya-
nodine receptor (21–23), we investigated how
colchicine-mediated JPH-2 restoration affected cal-
cium handling in isolated mdx cardiac myocytes
treated acutely with colchicine. Acute colchicine
treatment did not affect diastolic calcium, onset ki-
netics, or amplitude of calcium transients, but there
was accelerated calcium decay at 25% to baseline
(mdx: 59.4  2.5 ms andmdx-colchicine: 51.1  3.0 ms)
but not at 75% to baseline (mdx: 219.9  20.4 ms and
mdx-colchicine: 202.2  25.0 ms) (Figures 4A to 4F),
which suggested improved ryanodine receptor gating.
To further investigate ryanodine receptor activity, we
measured calcium spark frequency and found acute
colchicine treatment reduced calcium sparks by more
than 50% (mdx: 0.84  0.2 sparks/s/100 mm and
mdx-colchicine: 0.31  0.08 sparks/s/100 mm)
(Figures 4G and 4H). Acute colchicine treatment
caused a nonsigniﬁcant alteration in sarcoplasmic
reticulum calcium load (Supplemental Figure 1),
which would not explain the reduction in calcium
sparks. All together, these data suggest that acute
colchicine treatment improved ryanodine receptor
gating in mdx cardiac myocytes.
CHRONIC COLCHICINE TREATMENT DID NOT ALTER
ORGAN-LEVEL ASSESSMENTS OF CARDIOMYOPATHY IN
mdx MICE. Next, we determined if 2 weeks of colchi-
cine treatment led to whole-organ level improvementsin older mdx mice. M-mode echocardiography did not
reveal any signiﬁcant changes in cardiac geometry or
systolic function after 2 weeks of colchicine treatment
in mdx mice (Supplemental Figure 2), but both mdx
FIGURE 4 Colchicine Treatment Improved Calcium Handling in mdx Cardiac Myocytes
(A) Confocal micrographs of mdx cardiac myocytes stained with an a-tubulin antibody to show effective microtubule depolymerization with
colchicine treatment. (B) Representative curves of calcium transients. (C–E) Colchicine treatment did not affect baseline calcium, peak calcium,
or kinetics of onset of calcium transients, but increased calcium transient decay to 25% of baseline calcium levels (p ¼ 0.03). (F). N ¼ 20 cells
to 22 cells from 2 animals to 3 animals per treatment. (G) Representative calcium spark images from isolated mdx cardiac myocytes. Arrows
indicate calcium sparks. (H) Quantiﬁcation of calcium sparks frequency. Colchicine treatment signiﬁcantly reduced calcium sparks inmdx cardiac
myocytes (p ¼ 0.04). N ¼ 17 cells to 20 cells from 3 animals per treatment. *p # 0.05 as determined by Student t test. Values are presented as
mean  SEM.
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128groups showed signs of mild cardiomyopathy when
compared to age-matchedWTmice. Finally, colchicine
treatment did not confer a signiﬁcant survival beneﬁt
when older mdx mice were subjected to isoproterenol
stress test (WT survival: 75%,mdx-colchicine survival:
40%,mdx-PBS survival: 10%) (Supplemental Figure 3).
DISCUSSION
Our main new ﬁndings are the following: 1) t-tubule
disarray in mdx cardiac myocytes is associated with
altered localization and decreased protein levels of
JPH-2; 2) there is a signiﬁcant inverse hyperbolic
relationship between JPH-2 and a- and b-tubulin, the
individual subunits of microtubules, in mdx hearts; 3)
disruption of the JPH-2/microtubule relationship,
using colchicine to depolymerize microtubules, not
only normalizes JPH-2 localization, but we show for
the ﬁrst time that it restores JPH-2 protein levelswhich corrects t-tubule morphology; and 4) colchi-
cine treatment can effectively reduce calcium spark
frequency in isolated mdx cardiac myocytes, which
we propose is mediated through stabilization of the
ryanodine receptor. Collectively, these results pro-
vide evidence that microtubule-dependent mis-
regulation of JPH-2 underlies t-tubule derangements
and abnormal calcium handling in Duchenne cardio-
myopathy, and implicates JPH-2 as a new molecular
mediator in the pathophysiology of Duchenne
cardiomyopathy.
Importantly, our results provide additional
mechanistic insight into 2 secondary pathological
cardiac phenotypes associated with dystrophin-
deﬁciency: t-tubule disruptions and calcium mis-
handling. First of all, we show that normalization of
JPH-2 protein levels and localization improves
t-tubule architecture, a cellular phenotype that
has not had a proposed molecular mechanism.
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129Secondly, colchicine treatment reduces calcium
spark frequency which was in agreement with re-
sults of Kerr et al. (24), which we propose is due to
normalization of JPH-2 after microtubule depoly-
merization leading to improved ryanodine receptor
gating. These results provide an additional molecular
mechanism by which the ryanodine receptor gating
is altered in mdx cardiac myocytes, in addition to
the loss of a calstabin-ryanodine receptor interaction
as previously deﬁned (4). In summary, our results
implicate JPH-2 as the molecular mediator of
t-tubule abnormalities and abnormal gating of the
ryanodine receptor in Duchenne cardiomyopathy.
Next, we provide further support for the hypoth-
esis that JPH-2 regulates ryanodine receptor activity.
Several studies have documented increased calcium
spark frequency when JPH-2 is decreased or altered
in localization (9,21–23), suggesting the ryanodine
receptor is improperly gated when JPH-2 is dis-
rupted. In particular, Zhang et al. (9) showed that
microtubule depolymerization-induced normaliza-
tion of JPH-2 localization patterns reduced calcium
spark frequency in cultured mouse cardiac myo-
cytes, a result very similar to our ﬁndings. However,
unlike Zhang et al. (9), we did not observe changes
in calcium transient amplitude with colchicine
treatment. The discrepancy between our results and
those of Zhang et al. (9) may be due in-part to SR
load as JPH-2 knockdown causes reduced SR calcium
content, but calcium transients normalized to SR
load are actually increased (22). Mdx mice have
normal SR calcium content (25) and are not signiﬁ-
cantly altered by colchicine treatment (Supplemental
Figure 1), which might explain why colchicine
treatment did not increase calcium transient ampli-
tude in mdx cardiac myocytes. Another explanation
for the differences between our results and those of
Zhang et al. (9) could relate to the timing of experi-
ments as we analyzed calcium transients in freshly
isolated cardiac myocytes whereas Zhang et al. (9)
showed normalization of calcium transients in cells
cultured for >48 h. Nonetheless, our results support a
crucial role for JPH-2 in regulating ryanodine receptor
activity.
Although we were able to document restoration of
t-tubule organization with colchicine treatment, we
did not observe organ-level cardiac improvements in
mdx mice. One explanation is that t-tubule correc-
tions do not always lead to improved whole organ
function; a ﬁnding that was documented in previous
publications. Firstly, t-tubule derangements precede
left ventricular dysfunction in the thoracic aortic
banded rat model (26). Moreover, while transgenicoverexpression of JPH-2 could prevent pathological
t-tubule remodeling and blunted the effects of aortic
banding; it did not completely prevent the onset of
heart failure (17). Another reason for the lack of
improvement of cardiomyopathy in mdx mice treated
with colchicine could be the relatively mild cardio-
myopathy of mdx mice. Whereas Guo et al. (17)
showed improvements in ejection fraction with
JPH-2 overexpression, there was not a complete
normalization of ejection fraction, which could
explain why echocardiography did not reveal im-
provements in mdx mice treated with colchicine as
the mdx mice had only mild reduced fractional
shortening (Supplemental Figure 2). Finally, the lack
of a signiﬁcant improvement in isoproterenol stress
test may be explained by the underlying patho-
physiology that was corrected with colchicine treat-
ment. Previously, membrane permeability was
associated with increased death in mdx mice when
treated with isoproterenol (10,15,16), and thus the
nonsigniﬁcant improvement in survival with colchi-
cine may have resulted from an inability to correct
cardiac myocytes permeability in mdx hearts. In
summary, there may be several reasons why
colchicine treatment did not improve mdx
cardiomyopathy.
Finally, our results add to several other publica-
tions that document a crucial role for JPH-2 in t-tu-
bule integrity. The ﬁrst link between JPH-2 and
t-tubules was shown when knockout of JPH-2
resulted in embryonic lethality due to lack and car-
diac contractility and improper t-tubule formation
(27). Several other studies document that alterations
of JPH-2 via miR-24 (28,29), RNA interference
(21,22,30), or calpain-mediated protein cleavage (23)
cause t-tubule derangements and rescue of JPH-2
protein levels or localization via transgenic over-
expression (17), inhibition of miR-24 (28), calpain-
inhibition (23), or microtubule depolymerization (9)
prevent pathological t-tubule remodeling. Taken
together with our new ﬁndings, JPH-2 is a
critical mediator of t-tubule structure in cardiac
myocytes.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Cardio-
myopathy accounts for approximately one-quarter of
deaths in Duchenne muscular dystrophy. Currently, our
knowledge of the mechanistic pathophysiology of the
Duchenne cardiomyopathy is incomplete, but these data
provide a molecular explanation for the disruption of
t-tubules and calcium mishandling in Duchenne
cardiomyopathy.
TRANSLATIONAL OUTLOOK: Future studies that
examine the effects of normalization of JPH-2 through
multiple mechanisms including colchicine treatment,
gene transfer, or micro-RNA inhibition in large animal
models of Duchenne cardiomyopathy with a more severe
phenotype could be conducted to gain further informa-
tion about how JPH-2 affects outcomes in Duchenne
cardiomyopathy. If results are positive, a clinical trial
examining the effects of colchicine in Duchenne muscular
dystrophy could be considered.
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